KESIMPTA
KESIMPTA
Approved
DIN Number
02511355
Drug Class
Human
Market Date
Apr 8, 2021
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02511355
AIG Number0153129002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AG12 OFATUMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
OFATUMUMABActive
Strength: 20 MG / 0.4 ML
Monograph: OFATUMUMAB